A novel role for autologous tumour cell vaccination in the immunotherapy of the poorly immunogenic B16-BL6 melanoma
- 30 June 1992
- journal article
- Published by Elsevier in Surgical Oncology
- Vol. 1 (3) , 199-208
- https://doi.org/10.1016/0960-7404(92)90065-s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Divergent effects of TNFα in the adoptive immunotherapy of a murine sarcomaJournal of Surgical Research, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapyCellular Immunology, 1991
- Suppressive Effects of Visceral Tumor on the Generation of Antitumor T Cells for Adoptive ImmunotherapyArchives of Surgery, 1991
- Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.The Journal of Experimental Medicine, 1991
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Active immunotherapy in colorectal cancerSeminars in Surgical Oncology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Spontaneous regional lymph node metastases of three variants of the B16 melanoma: Relationship to primary tumor size and pulmonary metastasJournal of Surgical Oncology, 1986